REGNon logo

Regeneron Pharmaceuticals Inc (REGN)

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injectio...

NASDAQHealthcareBiotechnologyUSA

Company Profile

Stock Code
REGN
ISIN Code
US75886F1075
Currency
US Dollar (USD)
IPO Date
1991-04-02

Contact Information

Company Address
777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707
Contact Phone
914 847 7000
Company Website
https://www.regeneron.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Dividend Yield
0.57%
Return on Assets (TTM)
6.13%
EBITDA
$999,999.99
Revenue (TTM)
$999,999.99